107 related articles for article (PubMed ID: 21782391)
1. YKL-40 (chitinase 3-like-1) as a biomarker for psoriasis vulgaris and pustular psoriasis.
Imai Y; Tsuda T; Aochi S; Futatsugi-Yumikura S; Sakaguchi Y; Nakagawa N; Iwatsuki K; Yamanishi K
J Dermatol Sci; 2011 Oct; 64(1):75-7. PubMed ID: 21782391
[No Abstract] [Full Text] [Related]
2. Chitinase-3-Like Protein 1 (YKL-40) Is a New Biomarker of Inflammation in Psoriasis.
Salomon J; Matusiak Ł; Nowicka-Suszko D; Szepietowski JC
Mediators Inflamm; 2017; 2017():9538451. PubMed ID: 28932021
[TBL] [Abstract][Full Text] [Related]
3. Plasma YKL-40: a potential biomarker for psoriatic arthritis?
Jensen P; Wiell C; Milting K; Poggenborg RP; Østergaard M; Johansen JS; Skov L
J Eur Acad Dermatol Venereol; 2013 Jul; 27(7):815-9. PubMed ID: 22621388
[TBL] [Abstract][Full Text] [Related]
4. Serum YKL-40: a potential biomarker for psoriasis or endothelial dysfunction in psoriasis?
Erfan G; Guzel S; Alpsoy S; Rifaioglu EN; Kaya S; Kucukyalcın V; Topcu B; Kulac M
Mol Cell Biochem; 2015 Feb; 400(1-2):207-12. PubMed ID: 25421412
[TBL] [Abstract][Full Text] [Related]
5. Chitinase-3-like Protein 1 (YKL-40): Novel Biomarker of Hidradenitis Suppurativa Disease Activity?
Matusiak Ł; Salomon J; Nowicka-Suszko D; Bieniek A; Szepietowski JC
Acta Derm Venereol; 2015 Jul; 95(6):736-7. PubMed ID: 25655759
[No Abstract] [Full Text] [Related]
6. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma.
Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G
J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340
[TBL] [Abstract][Full Text] [Related]
7. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings.
Ahmed SF; Attia EA; Saad AA; Sharara M; Fawzy H; El Nahrery EM
J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):682-8. PubMed ID: 25087779
[TBL] [Abstract][Full Text] [Related]
8. Pretransplant serum human chitinase-like glycoprotein YKL-40 concentrations independently predict bronchiolitis obliterans development in lung transplant recipients.
Jaksch P; Taghavi S; Klepetko W; Salama M
J Thorac Cardiovasc Surg; 2014 Jul; 148(1):273-81. PubMed ID: 24685381
[TBL] [Abstract][Full Text] [Related]
9. YKL-40 is a serum biomarker reflecting the severity of cutaneous lesions in psoriatic arthritis.
Imai Y; Aochi S; Iwatsuki K; Sano H; Yamanishi K
J Dermatol; 2013 Apr; 40(4):294-6. PubMed ID: 23397985
[No Abstract] [Full Text] [Related]
10. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome.
Wang X; Xing GH
Scand J Clin Lab Invest; 2014 Jan; 74(1):74-8. PubMed ID: 24405178
[TBL] [Abstract][Full Text] [Related]
11. Serum YKL-40 levels as a novel marker of inflammation in patients with endometriosis.
Ural UM; Tekin YB; Cüre M; Şahin FK
Clin Exp Obstet Gynecol; 2015; 42(4):495-7. PubMed ID: 26411218
[TBL] [Abstract][Full Text] [Related]
12. Serum YKL-40 levels as a prognostic factor in patients with intracerebral hemorrhage.
Jiang YX; Zhang GH; Wang ZM; Yang H
Clin Biochem; 2014 Dec; 47(18):302-6. PubMed ID: 25262987
[TBL] [Abstract][Full Text] [Related]
13. Serum YKL-40 is increased in patients with slow coronary flow.
Xu Y; Meng HL; Su YM; Chen C; Huang YH; Li XF; Fan MK; Yan YJ; Wu J; Jiang MH; Pan M
Coron Artery Dis; 2015 Mar; 26(2):121-5. PubMed ID: 25356814
[TBL] [Abstract][Full Text] [Related]
14. Serum YKL-40 levels are altered in endometriosis.
Tuten A; Kucur M; Imamoglu M; Oncul M; Acikgoz AS; Sofiyeva N; Ozturk Z; Kaya B; Oral E
Gynecol Endocrinol; 2014 May; 30(5):381-4. PubMed ID: 24533749
[TBL] [Abstract][Full Text] [Related]
15. The inflammatory biomarker YKL-40 as a new prognostic marker for all-cause mortality in patients with heart failure.
Harutyunyan M; Christiansen M; Johansen JS; Køber L; Torp-Petersen C; Kastrup J
Immunobiology; 2012 Jun; 217(6):652-6. PubMed ID: 22209156
[TBL] [Abstract][Full Text] [Related]
16. Correlation between serum YKL-40 (chitinase-3-like protein 1) level and proteinuria in renal transplant recipients.
Tatar E; Gungor O; Celtik A; Sisman AR; Yaprak M; Asci G; Ozkahya M; Toz H
Ann Transplant; 2013 Mar; 18():95-100. PubMed ID: 23792508
[TBL] [Abstract][Full Text] [Related]
17. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
[TBL] [Abstract][Full Text] [Related]
18. Serum YKL-40 and uterine artery Doppler -- a prospective cohort study, with focus on preeclampsia and small-for-gestational-age.
Gybel-Brask D; Høgdall E; Johansen J; Christensen IJ; Skibsted L
Acta Obstet Gynecol Scand; 2014 Aug; 93(8):817-24. PubMed ID: 24861484
[TBL] [Abstract][Full Text] [Related]
19. The inflammatory biomarker YKL-40 at admission is a strong predictor of overall mortality.
Mygind ND; Iversen K; Køber L; Goetze JP; Nielsen H; Boesgaard S; Bay M; Johansen JS; Nielsen OW; Kirk V; Kastrup J
J Intern Med; 2013 Feb; 273(2):205-16. PubMed ID: 23140269
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum YKL-40 level predicts poor prognosis in hepatocellular carcinoma after surgery.
Zhu CB; Chen LL; Tian JJ; Su L; Wang C; Gai ZT; Du WJ; Ma GL
Ann Surg Oncol; 2012 Mar; 19(3):817-25. PubMed ID: 21861215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
